openPR Logo
Press release

Bile Duct Cancer (Cholangiocarcinoma) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | AstraZeneca, Basilea, Cellestia, Eisai, Eli Lilly, Elicio, Merck, Genoscience

11-29-2023 07:33 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Bile Duct Cancer (Cholangiocarcinoma) Pipeline Analysis

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 70+ key pharma and biotech companies are working on 70+ pipeline drugs in the Bile Duct Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Bile Duct Cancer (Cholangiocarcinoma) Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Bile Duct Cancer Therapeutics Market.

The report provides a detailed description of the Bile Duct Cancer drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Bile Duct Cancer Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/bile-duct-cancer-cholangiocarcinoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Bile Duct Cancer (Cholangiocarcinoma)Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Bile Duct Cancer therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Bile Duct Cancer treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Bile Duct Cancer drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Bile Duct Cancer treatment market.

Learn More about the Clinical and Commercial Development Activities in the Bile Duct Cancer Therapeutics Domain @
https://www.delveinsight.com/report-store/bile-duct-cancer-cholangiocarcinoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Analysis
Several major pharma and biotech companies are developing therapies for Cholangiocarcinoma. Currently, ImmunoGen is leading the therapeutics market with its Cholangiocarcinoma drug candidates in the most advanced stage of clinical development.

Bile Duct Cancer Companies in the Therapeutics Market Include:
3D Medicines, AstraZeneca, Basilea Pharmaceutica, Boehringer Ingelheim, Bold Therapeutics, Bristol-Myers Squibb, Cellestia Biotech, Chia Tai Tianqing Pharmaceutical, CSPC Ouyi Pharmaceutical Co., Ltd., Eisai Inc., Elevation oncology, Eli Lilly and Company, Elicio Therapeutics, Elucida Oncology, EMD Serono/Merck, Forma Therapeutics, Genoscience Pharma, Hutchison Medipharma Limited, Immunitor LLC, InnoCare Pharma, Intensity therapeutics, Janssen Pharmaceuticals, Jiangsu HengRui Medicine, Klus Pharma, Leap therapeutics, Merck Sharp & Dohme Corp., Newish Technology (Beijing) Co., Ltd., NGM Biopharmaceuticals, PCI Biotech AS, PCI Biotech AS, PureTech, QED Therapeutics, RedHill Biopharma, Relay Therapeutics, Senhwa Biosciences, Servier, Sirnaomics, Syndax Pharmaceuticals, Taiho Oncology, TCR2 therapeutics, TransThera Sciences, and others.

Emerging and Marketed Bile Duct Cancer Therapies Covered in the Report Include:
• Derazantinib: Basilea Pharmaceutica
• E7090: Eisai
• Entrectinib: Hoffmann-La Roche
• Erdafitinib: Janssen Research and Development
• Infigratinib: QED Therapeutics
• Ivosidenib: Agios Pharmaceuticals
• Larotrectinib: Loxo Oncology
• Melphalan Hydrochloride: Delcath Systems
• Pembrolizumab: Merck Sharp & dohme
• Pemigatinib: Incyte Corporation
• Regorafenib: Bayer
• TAS-120: Taiho Oncology
And Many More

Get an in-depth Assessment of the Emerging Therapies and Bile Duct Cancer Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/bile-duct-cancer-cholangiocarcinoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Bile Duct Cancer Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Cholangiocarcinoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Request for Sample PDF to Understand More About the Bile Duct Cancer Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/bile-duct-cancer-cholangiocarcinoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Bile Duct Cancer Current Treatment Patterns
4. Bile Duct Cancer - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Bile Duct Cancer Late-Stage Products (Phase-III)
7. Bile Duct Cancer Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Bile Duct Cancer Discontinued Products
13. Bile Duct Cancer Product Profiles
14. Bile Duct Cancer Companies
15. Bile Duct Cancer Drugs
16. Dormant and Discontinued Products
17. Bile Duct Cancer Unmet Needs
18. Bile Duct Cancer Future Perspectives
19. Bile Duct Cancer Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/bile-duct-cancer-cholangiocarcinoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Metrorrhagia Market
https://www.delveinsight.com/report-store/metrorrhagia-market

Dysfunctional Uterine Bleeding Market
https://www.delveinsight.com/report-store/dysfunctional-uterine-bleeding-market

Status Epilepticus Market
https://www.delveinsight.com/report-store/status-epilepticus-market

Brain Hemorrhage Market
https://www.delveinsight.com/report-store/brain-hemorrhage-market

Congenital Adrenal Hyperplasia Market
https://www.delveinsight.com/report-store/congenital-adrenal-hyperplasia-market

Ductal Carcinoma in Situ Market
https://www.delveinsight.com/report-store/ductal-carcinoma-in-situ-market

Electroencephelographs (EEG) Pipeline Insight
https://www.delveinsight.com/report-store/electroencephelographs-eeg-pipeline-insight-and-competitive-landscape

Spinal Decompression/Traction Devices Market
https://www.delveinsight.com/report-store/spinal-decompression-traction-devices-market

Bronchopulmonary Dysplasia Market
https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market

Drug Hypersensitivity Market
https://www.delveinsight.com/report-store/drug-hypersensitivity-market

Familial Chylomicronemia Syndrome (FCS) Market
https://www.delveinsight.com/report-store/familial-chylomicronemia-syndrome-market

Implantable Infusion Pumps Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market

Postmyocardial Infarction Syndrome Market
https://www.delveinsight.com/report-store/postmyocardial-infarction-syndrome-market

Surgery and Radiation Therapy in Brain Cancer Market
https://www.delveinsight.com/report-store/surgery-and-radiation-therapy-in-brain-cancer-market

Acute ischemic stroke (AIS) Market
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market

Acute On Chronic Liver Failure (ACLF) Market
https://www.delveinsight.com/report-store/acute-on-chronic-liver-failure-aclf-market

Biliary Tract Cancers (BTCs) Market
https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market

Gene Therapy for Ocular Rare Disease Market
https://www.delveinsight.com/report-store/gene-therapy-for-ocular-rare-disease-market

Hemophagocytic Lymphohistiocytosis Market
https://www.delveinsight.com/report-store/hemophagocytic-lymphohistiocytosis-market

Staphylococcus Aureus Infection Market
https://www.delveinsight.com/report-store/staphylococcus-aureus-infection-market

Treatment-Resistant Hypertension Market
https://www.delveinsight.com/report-store/treatment-resistant-hypertension-market

Urticaria Or Hives Market
https://www.delveinsight.com/report-store/urticaria-or-hives-market

Acute Heart failure Market
https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market

Bowen's Disease Market
https://www.delveinsight.com/report-store/bowens-disease-market

Contrast-Induced Nephropathy Market
https://www.delveinsight.com/report-store/contrast-induced-nephropathy-market

Delirium Market
https://www.delveinsight.com/report-store/delirium-market

Dry AMD MarketEGFR Inhibitors-Induced Skin Disorders Market
https://www.delveinsight.com/report-store/egfr-inhibitors-induced-skin-disorders-market

Excessive Daytime Sleepiness (EDS) Market
https://www.delveinsight.com/report-store/excessive-daytime-sleepiness-eds-market

Gene and Cell Therapies Targeting CNS Disorders Market
https://www.delveinsight.com/report-store/gene-and-cell-therapies-targeting-cns-disorders-market

Glioma Market
https://www.delveinsight.com/report-store/glioma-market

Graves Ophthalmopathy Market
https://www.delveinsight.com/report-store/graves-ophthalmopathy-market

H3N2 Infection Market
https://www.delveinsight.com/report-store/h3n2-infection-market

Nontuberculous Mycobacterial (NTM) Infections Market
https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-ntm-infections-market

Pars Plantis Market
https://www.delveinsight.com/report-store/pars-plantis-market

Pneumothorax Treatment Devices Market
https://www.delveinsight.com/report-store/pneumothorax-treatment-devices-market

Portal Hypertension Market
https://www.delveinsight.com/report-store/portal-hypertension-market

Decompensated Cirrhosis Market
https://www.delveinsight.com/report-store/decompensated-cirrhosis-market

Follicular Lymphoma Market
https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights

Osteochondromas Market
https://www.delveinsight.com/report-store/osteochondromas-market

Hidradenitis Suppurativa Market
https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market

IgG4-Related Disease Market
https://www.delveinsight.com/report-store/igg4-related-disease-market

Lichen Planus Market
https://www.delveinsight.com/report-store/lichen-planus-market

Retinal Vein Occlusion Market
https://www.delveinsight.com/report-store/retinal-vein-occlusion-market

Meniere's Disease Market
https://www.delveinsight.com/report-store/menieres-disease-md-market

Cytokine Release Syndrome Market
https://www.delveinsight.com/report-store/cytokine-release-syndrome-market

Angelman Syndrome Market
https://www.delveinsight.com/report-store/angelman-syndrome-market-forecast

Eosinophilic Gastroenteritis (EGE) Market
https://www.delveinsight.com/report-store/eosinophilic-gastroenteritis-ege-market

Hereditary Transthyretin Amyloidosis (hATTR) Market
https://www.delveinsight.com/report-store/hereditary-transthyretin-amyloidosis-competitive-landscape-and-market

Implantable Infusion Pumps Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market

Post-Operative Cataract Surgery Inflammation Market
https://www.delveinsight.com/report-store/post-operative-cataract-surgery-inflammation-market

Antibody-mediated Rejection Market
https://www.delveinsight.com/report-store/antibody-mediated-rejection-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bile Duct Cancer (Cholangiocarcinoma) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | AstraZeneca, Basilea, Cellestia, Eisai, Eli Lilly, Elicio, Merck, Genoscience here

News-ID: 3309398 • Views:

More Releases from DelveInsight Business Research LLP

Fragile X Syndrome (FXS) Pipeline Assessment Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Alcobra, Actinogen, Autifony, Healx, Roche, Lysogene, Marinus Pharmaceuticals, Neuren Pharma, NovaMentis, Novartis, Prilenia
Fragile X Syndrome (FXS) Pipeline Assessment Covering Clinical Trials, Emerging …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 20+ pipeline drugs in the Fragile X Syndrome therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Fragile X Syndrome (FXS) Pipeline
Acute Kidney Injury Pipeline Assessment Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | AM-Pharma, Alexion, Alloksys, Aptabio Therapeutics, ArchBiopartners, Novartis, Ocelot Bio, River2Renal, Sentien
Acute Kidney Injury Pipeline Assessment Covering Clinical Trials, Emerging Thera …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Acute Kidney Injury therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Acute Kidney Injury Pipeline Insight"
Retinitis Pigmentosa Pipeline Assessment Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | MeiraGTx, Aldeyra, SparingVision, ProQR Therapeutics, RetroSense, Endogena, Nacuity Pharmaceuticals, jCyte, Ocugen, Neurotech
Retinitis Pigmentosa Pipeline Assessment Covering Clinical Trials, Emerging Ther …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 40+ pipeline drugs in the Retinitis Pigmentosa therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Retinitis Pigmentosa Pipeline Insight" report by
Schizophrenia Pipeline Assessment Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Avanir, Boehringer Ingelheim, Cyclerion, Heptares, Medicell, Merck, Otsuka, Recognify, PsychoGenics, SyneuRx, Takeda, Valentech, Vigonvita
Schizophrenia Pipeline Assessment Covering Clinical Trials, Emerging Therapies, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 70+ key pharma and biotech companies are working on 70+ pipeline drugs in the Schizophrenia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Schizophrenia Pipeline Insight" report by DelveInsight provides

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top